The quest to find new lead compounds with anti-diabetic effects via the inhibition of α-glucosidase and α-amylase had led us to conduct bioassay guided isolation of three African medicinal plants which resulted in the identification of bicyclo[2.2.0]hexane-2,3,5-triol (1), 3β-O-acetyl betulinic acid (2) and 2,7-dihydroxy-4H-1-benzopyran-4-one (3), as the bioactive compounds. The compounds demonstrated a significant (P < 0.05) inhibitory effect on α-glucosidase and α-amylase activities than acarbose. Steady state kinetic analysis revealed that compounds 1 and 2 inhibited both α-amylase and α-glucosidase in non-competitive patterns whilst compound 3 was an uncompetitive inhibitor of α-glucosidase and a non-competitive inhibitor of α-amylase. In conclusion, the study has identified three new active α-glucosidase and α-amylase inhibitory compounds that could have the potential to retard postprandial hyperglycemia.
StumvollM., GoldsteinB.J., van HaeftenT.W. (2008) Type 2 diabetes: pathogenesis and treatment. Lancet, 371, 2153–2156.
2.
(a) Kawamura-KonishiY., WatanabeN., SaitoM., NakajimaN., SakakiT., KatayamaT., EnomotoT. (2012) Isolation of a new phlorotannin, a potent inhibitor of carbohydrate- hydrolyzing enzymes, from the brown alga Sargassum patens. Journal of Agricultural and Food Chemistry, 60, 5565–5570; (b) Lordan S, Smyth TJ, Soler-Vila A, Stanton C, Ross P. (2013) The α-amylase and α-glucosidase inhibitory effects of Irish seaweed extracts. Food Chemistry, 141, 2170–2176; (c) Zhang Z, Luo A, Zhong K, Huang Y, Gao Y, Zhang J. (2013) α-Glucosidase inhibitory activity by the flower buds of Lonicera japonica Thunb. Journal of Functional Foods, 5, 1253–1259.
3.
(a) FujisawaT., IkegamiH., InoueK., KawabataY., OgiharaT. (2005) Effect of two α-glucosidase inhibitors, voglibose and acarbose, on postprandial hyperglycemia correlates with subjective abdominal symptoms. Metabolism, 54, 387–390; (b) Li DQ, Zhao J, Xie J, Li SP. (2014) A novel simple preparation and on-line HPLC-DAD-MS/MS-BCD analysis for rapid screening and characterization of specific enzyme inhibitors in herbal extracts: case study of α-glucosidase. Journal of Pharmaceutical and Biomedical Analysis, 88, 130–135.
4.
Yilmazer-MusaM., GriffithA.M., MichelsA.J., SchneiderE., FreiB. (2012) Grape seed and tea extracts and catechin 3-gallates are potent inhibitors of α-amylase and α-glucosidase activity. Journal of Agricultural and Food Chemistry, 60, 8924–8929.
5.
MohammedA., IbrahimM.A., IslamM.S. (2014) African medicinal plants with anti-diabetic potentials: a review. Planta Medica, 80, 354–377.
6.
IbrahimM.A., KoorbanallyN., IslamM.S. (2014) Anti-oxidative activity and inhibition of key enzymes linked to type 2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis. Acta Pharmaceutica, 64, 311–324.
7.
IbrahimM.A., IslamM.S. (2014) Butanol fraction of Khaya senegalensis root modulates β-cell function and ameliorates diabetes-related biochemical paramaters in a type 2 diabetes rat model. Journal of Ethnopharmacology, 154, 832–838.
8.
IbrahimM.A., IslamM.S. (2014) Anti-diabetic effects of the acetone fraction of Senna singueana stem bark in a type 2 diabetes model of rats. Journal of Ethnopharmacology, 153, 392–399.
9.
AhmedF.B.H., MoghaddamM.G., BasriM., Abdul RahmanM.B. (2010) Anticancer activity of 3-O- acetylated betulinic acid derivatives obtained by enzymatic synthesis. Bioscience, Biotechnology and Biochemistry, 74, 1025–1029.
10.
LaiW., WangH., ChenG., YangJ., KorinekM., HsiehC., NozakiH., HayashiK., WuC., WuY., ChangF. (2011) Using the pER8:GUS reporter system to screen for phytoestrogens from Caesalpinia sappan. Journal of Natural Products, 74, 1608–1706.
11.
ChibberS.S., SharmaR.P. (1978) Tautomerism of 2-hydroxychromones and 4-hydroxycoumarins. Current Science, 47, 730–731.
12.
KoehnF.E., CarterG.T. (2004) The evolving role of natural products in drug discovery. Nature Reviews in Drug Discovery, 4, 206–220.
13.
(a) NewmanD.J., CraggG.M., SnaderK.M. (2003) Natural products as sources of new drugs over the period 1981–2002. Journal of Natural Products, 66, 1022–1032; (b) Gupta R, Gabrielsen B, Ferguson FM. (2005) Nature's medicines: traditional knowledge and intellectual property management. case studies from the National Institutes of Health (NIH), USA. Current Drug Discovery and Technology, 2, 203–219.
14.
KayserO., AbreuP.M. (2001) Antileishmania and immunostimulating activities of two dimeric proanthocyanidins from Khaya senegalensis. Pharmaceutical Biology, 39, 284–288.
15.
AbdelgaleilS.A.M., IwagawaT., DoeM., NakataniM. (2004) Antifungal limonoids from the fruits of Khaya senegalensis. Fitoterapia, 75, 566–572.
16.
ZhangH., TanJ., VanDerveerD., WangX., WargovichM.J., ChenF. (2009) Khayanolides from African mahogany Khaya senegalensis (Meliaceae): A revision. Phytochemistry, 70, 294–299.
17.
YuanT., ZhangC., YangS., YueJ. (2010) Limonoids and triterpenoids from Khaya senegalensis. Journal of Natural Products, 73, 669–674.
18.
(a) PiparoE.L., ScheibH., FreiN., WilliamsonG., GrigorovM., ChouC.J. (2008) Flavonoids for controlling starch digestion: structural requirements for inhibiting human α-amylase. Journal of Medicinal Chemistry, 51, 3555–3561; (b) Sheng H, Sun H. (2011) Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases. Natural Product Reports, 28, 543–593; (c) Ibrahim MA, Aliyu AB, Abusufiyanu A, Bashir M, Sallau AB. (2011) Inhibition of Naja nigricolis (Reinhardt) venom protease activity by Luffa egyptiaca (Mill) and Nicotiana rustica (Linn) extracts. Indian Journal of Experimental Biology, 49, 552–554.
19.
(a) AuvinC., LezenvenF., Augeven-BourI., BodoB., CamaraJ. (1996) Mucronine J, a 14-membered cyclopeptide alkaloid from Zizyphus mucronata. Journal of Natural Products, 59, 676–678; (b) Mokgolodi NC, Hu Y, Shi L, Liu Y. (2011) Ziziphus mucronata: an underutilized traditional plant in Africa. Forestry Studies in China, 13, 163–172; (c) Kasabri V, Afifi FU, Hamdan I. (2011) In vitro and in vivo acute antihyperglycemic effects of five selected indigenous plants from Jordan used in traditional medicine. Journal of Ethnopharmacology, 133, 888–896.
20.
XuH. (2010) Inhibition kinetics of flavonoids on yeast α-glucosidase merged with docking simulations. Protein Peptide Letters, 17, 1270–1279.
21.
KrentzA.J., BaileC.J. (2005) Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs, 65, 385–411.
22.
AdemiluyiA.O., ObohG. (2013) Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro. Experimental and Toxicologic Pathology, 65, 305–309.
23.
ShaiL.J., MasokoP., MokgothoM.P., MaganoS.R., BoaduoN., EloffJ.N. (2010) Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South Africa. South African Journal of Botany, 76, 465–470.
